| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |